During the past decade, Seikeikai New Tokyo Heart Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seikeikai New Tokyo Heart Clinic" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Seikeikai New Tokyo Heart Clinic" are "Anemia" (2 trials), "Heart Failure" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Atrial Fibrillation" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Seikeikai New Tokyo Heart Clinic" in a lesser frequency.

Most popular intervention types in "Seikeikai New Tokyo Heart Clinic" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials) and "Linagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seikeikai New Tokyo Heart Clinic" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Seikeikai New Tokyo Heart Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Seikeikai New Tokyo Heart Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seikeikai New Tokyo Heart Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".